Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus-Michael Lehr

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 14, 2009
Biological barriers and nanomedicine--timely challenges in advanced drug delivery researchClaus-Michael Lehr
Microbial Biotechnology|August 23, 2011
Nanoparticles for transcutaneous vaccinationSteffi Hansen, Claus-Michael Lehr
Advanced Drug Delivery Reviews|February 19, 2004
Lectins and glycoconjugates in drug delivery and targetingClaus-Michael Lehr, Franz Gabor
Expert Opinion on Biological Therapy|March 14, 2002
Developments in the area of bioadhesive drug delivery systemsJochen Haas, Claus-Michael Lehr
Advanced Drug Delivery Reviews|April 15, 2021
Extracellular vesicles as novel assay tools to study cellular interactions of anti-infective compounds - A perspectiveRobert Richter, Claus-Michael Lehr
Expert Opinion on Drug Delivery|June 6, 2008
Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicinesMichael Bur, Claus-Michael Lehr
Expert Review of Vaccines|January 17, 2014
Transfollicular delivery takes root: the future for vaccine design?Steffi Hansen, Claus-Michael Lehr
Biomacromolecules|April 2, 2014
Design of starch-graft-PEI polymers: an effective and biodegradable gene delivery platformHiroe Yamada, Brigitta Loretz, Claus-Michael Lehr
Current Topics in Microbiology and Immunology|March 5, 2016
Anti-infectives in Drug Delivery-Overcoming the Gram-Negative Bacterial Cell EnvelopeFlorian Graef, Sarah Gordon, Claus-Michael Lehr
Current Pharmaceutical Design|December 15, 2015
Calcium Phosphate System for Gene Delivery: Historical Background and Emerging OpportunitiesBabak Mostaghaci, Brigitta Loretz, Claus-Michael Lehr
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 14, 2009
Biological barriers and nanomedicine--timely challenges in advanced drug delivery researchClaus-Michael Lehr
Microbial Biotechnology|August 23, 2011
Nanoparticles for transcutaneous vaccinationSteffi Hansen, Claus-Michael Lehr
Advanced Drug Delivery Reviews|February 19, 2004
Lectins and glycoconjugates in drug delivery and targetingClaus-Michael Lehr, Franz Gabor
Expert Opinion on Biological Therapy|March 14, 2002
Developments in the area of bioadhesive drug delivery systemsJochen Haas, Claus-Michael Lehr
Advanced Drug Delivery Reviews|April 15, 2021
Extracellular vesicles as novel assay tools to study cellular interactions of anti-infective compounds - A perspectiveRobert Richter, Claus-Michael Lehr
Expert Opinion on Drug Delivery|June 6, 2008
Pulmonary cell culture models to study the safety and efficacy of innovative aerosol medicinesMichael Bur, Claus-Michael Lehr
Expert Review of Vaccines|January 17, 2014
Transfollicular delivery takes root: the future for vaccine design?Steffi Hansen, Claus-Michael Lehr
Biomacromolecules|April 2, 2014
Design of starch-graft-PEI polymers: an effective and biodegradable gene delivery platformHiroe Yamada, Brigitta Loretz, Claus-Michael Lehr
Current Topics in Microbiology and Immunology|March 5, 2016
Anti-infectives in Drug Delivery-Overcoming the Gram-Negative Bacterial Cell EnvelopeFlorian Graef, Sarah Gordon, Claus-Michael Lehr
Current Pharmaceutical Design|December 15, 2015
Calcium Phosphate System for Gene Delivery: Historical Background and Emerging OpportunitiesBabak Mostaghaci, Brigitta Loretz, Claus-Michael Lehr
Pageof 33